Medico Remedies Ltd.

84.30 +0.52 ▲0.6%

09 June 2023, 04:01:00 PM
Volume: 11,231

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.medicoremediesindia.com / www.medicoremediesindia.net / www.tabletandcapsules.com
Market Cap 693.41 Cr.
Enterprise Value(EV) 699.33 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 0.87 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 95.74 Trailing Twelve Months Ending 2023-03
Industry PE 33.57 Trailing Twelve Months Ending 2023-03
Book Value / Share 5.28 Trailing Twelve Months Ending 2023-03
Price to Book Value 15.82 Calculated using Price: 83.56
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 8.30 Cr. 82,984,000 Shares
FaceValue 2
About Medico Remedies Ltd.
The company is engaged in manufacturing and selling of pharmaceutical formulation products in India. The company offers formulation pharmacy products including anti-infective, beta lactum, cephalosporin, antimalarial, antiretroviral, and anti-ulcer drugs, as well as antacids; vitamins, haematinics and other supplements and nonsteroidal anti-inflammatory drugs, antihistaminics, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and creams and gels.

Medico Remedies Ltd. Delivery

Delivered Qty
Traded Qty

Medico Remedies Ltd. Performance

1 Day
+0.62%
1 Week
-1.17%
1 Month
-1.37%
3 Month
+14.62%
6 Month
+32.65%
1 Year
+328.79%
2 Year
+1196.92%
5 Year
+1627.46%
10 Year

Medico Remedies Ltd. Fundamental Ratios

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 9.23 7.14 7.97 10.47 5.67 5.72 5.61 8.31 14.02
Return on Capital Employed (%) 11.37 10.01 10.86 9.39 9.05 7.79 7.66 10.13 15.00
Return on Assets (%) 2.54 2.36 2.78 3.47 2.26 2.31 2.15 3.43 6.44

Medico Remedies Ltd. Balance Sheet

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 9 14 15 16 27 28 30 32 37 44
Non Curr. Liab. 1 1 4 11 3 3 5 5 1 2
Curr. Liab. 22 22 26 21 30 45 40 38 38 42
Minority Int.
Equity & Liab. 31 36 46 48 59 76 75 76 76 87
Non Curr. Assets 8 10 9 10 14 17 19 17 18 23
Curr. Assets 23 26 37 38 46 59 57 58 59 65
Misc. Exp. not W/O
Total Assets 31 36 46 48 59 76 75 76 76 87

Medico Remedies Ltd. Profit and Loss

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 45 51 67 54 61 98 89 122 121 140
Other Income 0 0 0 0 1 2 2 1 2 4
Total Income 45 51 67 55 62 100 91 123 123 144
Total Expenditure -43 -48 -63 -50 -58 -95 -86 -117 -114 -131
PBIDT 2 3 4 4 4 5 5 6 9 14
Interest -1 -1 -1 -1 -2 -1 -1 -1 -1 -1
Depreciation -1 -1 -1 -1 -1 -2 -2 -2 -2 -3
Taxation 0 0 -1 0 -1 -1 -1 -1 -2 -3
Exceptional Items 0
PAT 1 1 1 2 1 2 2 3 5 7
Adjusted EPS 0 0 0 0 0 0 0 0 1 1

Medico Remedies Ltd. Cash Flow

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 3 0 -4 -3 5 5 1 -11 2
Cash Fr. Inv. -2 -4 -2 0 -3 -5 -4 -3 -17 -3
Cash Fr. Finan. 0 2 3 2 6 -1 -1 3 18 7
Net Change 0 1 0 -1 0 -1 0 0 -10 6
Cash & Cash Eqvt 0 1 2 1 0 0 0 1 -10 6

Medico Remedies Ltd. Shareholding Pattern

9 Qtrs 2020-09 (%) 2021-03 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 73.34 73.34 73.34 73.34 73.34 73.34 73.34 73.34 73.34
Public 26.66 26.66 26.66 26.66 26.66 26.66 26.66 26.66 26.66
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 12.94 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Medico Remedies Ltd. Announcements

Fri, 26 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Circular CIR/CFD/CMD1/27/2019 dated February 08 2019 for the purpose ofcompliance with Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements)Regulations 2015 please find enclosed herewith the Annual Secretarial Compliance Report forthe year ended 31st March 2023.
Sat, 13 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements)Regulations 2015 please find enclosed the newspaper advertisements published in FinancialExpress (English Edition) and in Mumbai Lakshadeep (Marathi Edition) dated 13th May 2023 forPublication of announcement of Audited Financial Results for the quarter and year ended 31stMarch 2023.
Sat, 13 May 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 please find enclosed herewith Press Release about "Medico Remedies Limited is pleased to announce its readiness to foray into ointment manufacturing segment.

Medico Remedies Ltd. Technical Scans

Fri, 09 Jun 2023
High Delivery Percentage High Delivery Percentage
Close Below Last Week Low Close Below Last Week Low
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year

Medico Remedies Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,890.62 983.15 -0.4%
Divi's Laboratories Ltd. 90,973.43 3,426.90 -2.1%
Cipla Ltd. 78,191.79 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. 77,768.81 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. 70,817.54 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. 61,150.32 1,810.90 +0.8%
Mankind Pharma Ltd. 59,389.24 1,482.30 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.84 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 49.89 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 27.91 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.25 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.63 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 49.23 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 46.32 1,482.30 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.13 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 3.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.34 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.46 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.89 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 5.05 1,482.30 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 0.04 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 0.14 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 7,781.56 1,482.30 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 1,452.96 1,482.30 +1.8%

Medico Remedies Ltd. FAQ's

What is Medico Remedies share price?

Can I buy Medico Remedies shares now?

What is the Market Cap of Medico Remedies?

What are the key metrics to analyse Medico Remedies?

What is the 52 Week High and Low of Medico Remedies?

What is the trend of Medico Remedies share price?